P012 Ozanimod Reduced Fecal Calprotectin Levels in Patients with Ulcerative Colitis in the Phase 3 True North Study

Am J Gastroenterol. 2020 Dec 1;115(Suppl 1):S3. doi: 10.14309/01.ajg.0000722844.18503.37.
No abstract available